Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats

Mol Brain. 2012 May 30:5:18. doi: 10.1186/1756-6606-5-18.

Abstract

Background: Spinal glia, particularly microglia and astrocytes, are of the utmost importance in the development and maintenance of chronic pain. A recent study from our laboratory revealed that gabapentin, a recommended first-line treatment for multiple neuropathic conditions, could also efficiently antagonize thermal hyperalgesia evoked by complete Freund's adjuvant (CFA)-induced monoarthritis (MA). In the present study, we investigated whether the spinal glia are involved in the anti-hyperalgesic effect of gabapentin and how this event occurs.

Results: Unilateral intra-articular injection of CFA produced a robust activation of microglia and astrocytes. These cells exhibited large cell bodies, thick processes and increases in the ionized calcium binding adapter molecule 1 (Iba-1, a microglial marker) or the glia fibrillary acidic protein (GFAP, an astrocytic marker). These cells also displayed immunoreactive signals, and an upregulation of the voltage-gated calcium channels (VGCCs) α2/δ-1 subunit, CX3CL1 and CX3CR1 expression levels in the spinal cord. These changes were associated with the development of thermal hyperalgesia. Immunofluorescence staining showed that VGCC α2/δ-1 subunit, a proposed gabapentin target of action, was widely distributed in primary afferent fibers terminals and dorsal horn neurons. CX3CL1, a potential trigger to activate microglia, colocalized with VGCC α2/δ-1 subunits in the spinal dorsal horn. However, its receptor CX3CR1 was mainly expressed in the spinal microglia. Multiple intraperitoneal (i.p.) gabapentin injections (100 mg/kg, once daily for 4 days with the first injection 60 min before intra-articular CFA) suppressed the activation of spinal microglia, downregulated spinal VGCC α2/δ-1 subunits decreased CX3CL1 levels and blocked the development of thermal hyperalgesia in MA rats.

Conclusions: Here we provide the first evidence that gabapentin diminishes CX3CL1 signaling and spinal microglia activation induced by joint inflammation. We also show that the VGCC α2/δ-1 subunits might be involved in these events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amines / administration & dosage
  • Amines / pharmacology*
  • Animals
  • Arthritis / complications
  • Arthritis / metabolism
  • Arthritis / pathology*
  • CX3C Chemokine Receptor 1
  • Calcium Channels, L-Type / metabolism
  • Chemokine CX3CL1 / metabolism*
  • Cyclohexanecarboxylic Acids / administration & dosage
  • Cyclohexanecarboxylic Acids / pharmacology*
  • Disease Models, Animal
  • Freund's Adjuvant
  • Gabapentin
  • Hyperalgesia / complications
  • Hyperalgesia / metabolism
  • Hyperalgesia / pathology
  • Injections, Intra-Articular
  • Injections, Intraperitoneal
  • Lumbar Vertebrae / pathology
  • Male
  • Microglia / drug effects
  • Microglia / metabolism
  • Microglia / pathology*
  • Models, Biological
  • Pain / metabolism
  • Pain / pathology
  • Posterior Horn Cells / drug effects
  • Posterior Horn Cells / metabolism
  • Posterior Horn Cells / pathology
  • Protein Subunits / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Chemokine / metabolism
  • Signal Transduction / drug effects*
  • Spinal Cord / pathology*
  • Time Factors
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / pharmacology*

Substances

  • Amines
  • CX3C Chemokine Receptor 1
  • CX3CR1 protein, rat
  • Calcium Channels, L-Type
  • Chemokine CX3CL1
  • Cx3cl1 protein, rat
  • Cyclohexanecarboxylic Acids
  • Protein Subunits
  • Receptors, Chemokine
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Freund's Adjuvant